Early diagnosis of acute kidney injury: The promise of novel biomarkers

Sachin S. Soni, Claudio Ronco, Nevin Katz, Dinna N. Cruz

Research output: Contribution to journalArticle

Abstract

The incidence of acute kidney injury (AKI) formerly referred to as acute renal failure (ARF) is increasing to epidemic proportions. Development of AKI portends excessive morbidity and mortality. AKI is associated with prolonged hospital stay, increased healthcare costs and high mortality especially in critically ill patients. The mortality rate has remained largely unchanged for many decades. Delay in the diagnosis of AKI using conventional biomarkers like urine output and serum creatinine has been one of the important obstacles in applying effective early interventions. Several new biomarkers are being evaluated in a quest for early diagnosis of AKI, among which neutrophil gelatinase-associated lipocalin (NGAL) appears to be one of the most promising. This review summarizes the recent literature on these biomarkers.

Original languageEnglish (US)
Pages (from-to)165-174
Number of pages10
JournalBlood Purification
Volume28
Issue number3
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Acute Kidney Injury
Early Diagnosis
Biomarkers
Mortality
Critical Illness
Health Care Costs
Length of Stay
Creatinine
Urine
Morbidity
Incidence
Serum

Keywords

  • Acute kidney injury
  • Acute Kidney Injury Network (AKIN)
  • Acute renal failure
  • Neutrophil gelatinase-associated lipocalin
  • RIFLE Classification

ASJC Scopus subject areas

  • Nephrology
  • Hematology

Cite this

Early diagnosis of acute kidney injury : The promise of novel biomarkers. / Soni, Sachin S.; Ronco, Claudio; Katz, Nevin; Cruz, Dinna N.

In: Blood Purification, Vol. 28, No. 3, 10.2009, p. 165-174.

Research output: Contribution to journalArticle

Soni, Sachin S. ; Ronco, Claudio ; Katz, Nevin ; Cruz, Dinna N. / Early diagnosis of acute kidney injury : The promise of novel biomarkers. In: Blood Purification. 2009 ; Vol. 28, No. 3. pp. 165-174.
@article{9a03016d46d9477faa9be7886261004d,
title = "Early diagnosis of acute kidney injury: The promise of novel biomarkers",
abstract = "The incidence of acute kidney injury (AKI) formerly referred to as acute renal failure (ARF) is increasing to epidemic proportions. Development of AKI portends excessive morbidity and mortality. AKI is associated with prolonged hospital stay, increased healthcare costs and high mortality especially in critically ill patients. The mortality rate has remained largely unchanged for many decades. Delay in the diagnosis of AKI using conventional biomarkers like urine output and serum creatinine has been one of the important obstacles in applying effective early interventions. Several new biomarkers are being evaluated in a quest for early diagnosis of AKI, among which neutrophil gelatinase-associated lipocalin (NGAL) appears to be one of the most promising. This review summarizes the recent literature on these biomarkers.",
keywords = "Acute kidney injury, Acute Kidney Injury Network (AKIN), Acute renal failure, Neutrophil gelatinase-associated lipocalin, RIFLE Classification",
author = "Soni, {Sachin S.} and Claudio Ronco and Nevin Katz and Cruz, {Dinna N.}",
year = "2009",
month = "10",
doi = "10.1159/000227785",
language = "English (US)",
volume = "28",
pages = "165--174",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Early diagnosis of acute kidney injury

T2 - The promise of novel biomarkers

AU - Soni, Sachin S.

AU - Ronco, Claudio

AU - Katz, Nevin

AU - Cruz, Dinna N.

PY - 2009/10

Y1 - 2009/10

N2 - The incidence of acute kidney injury (AKI) formerly referred to as acute renal failure (ARF) is increasing to epidemic proportions. Development of AKI portends excessive morbidity and mortality. AKI is associated with prolonged hospital stay, increased healthcare costs and high mortality especially in critically ill patients. The mortality rate has remained largely unchanged for many decades. Delay in the diagnosis of AKI using conventional biomarkers like urine output and serum creatinine has been one of the important obstacles in applying effective early interventions. Several new biomarkers are being evaluated in a quest for early diagnosis of AKI, among which neutrophil gelatinase-associated lipocalin (NGAL) appears to be one of the most promising. This review summarizes the recent literature on these biomarkers.

AB - The incidence of acute kidney injury (AKI) formerly referred to as acute renal failure (ARF) is increasing to epidemic proportions. Development of AKI portends excessive morbidity and mortality. AKI is associated with prolonged hospital stay, increased healthcare costs and high mortality especially in critically ill patients. The mortality rate has remained largely unchanged for many decades. Delay in the diagnosis of AKI using conventional biomarkers like urine output and serum creatinine has been one of the important obstacles in applying effective early interventions. Several new biomarkers are being evaluated in a quest for early diagnosis of AKI, among which neutrophil gelatinase-associated lipocalin (NGAL) appears to be one of the most promising. This review summarizes the recent literature on these biomarkers.

KW - Acute kidney injury

KW - Acute Kidney Injury Network (AKIN)

KW - Acute renal failure

KW - Neutrophil gelatinase-associated lipocalin

KW - RIFLE Classification

UR - http://www.scopus.com/inward/record.url?scp=67649886919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649886919&partnerID=8YFLogxK

U2 - 10.1159/000227785

DO - 10.1159/000227785

M3 - Article

C2 - 19590184

AN - SCOPUS:67649886919

VL - 28

SP - 165

EP - 174

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 3

ER -